Curaleaf CEO talks unsolicited offer to buy Aurora Cannabis
Спикеры
Boris Jordan
— Генеральный директор, Galaxy Digital
Tim Seymour
— Seymour Asset Management, Fast Money Trader
Curaleaf CEO Boris Jordan discusses his unsolicited bid for Aurora Cannabis and why he sees it as a strong strategic fit. He argues Curaleaf needs Aurora's Canadian production capacity to supply its European/Asian distribution, while Aurora's standalone business is shrinking. Tim Seymour adds that the deal highlights multiple bullish signals for the cannabis industry.
- Curaleaf made an unsolicited offer for Aurora Cannabis, and Aurora formed a special committee.
- Boris Jordan says Curaleaf has strong Europe/Asia distribution but is supply-constrained, while Aurora's Canadian facilities can nearly double productivity.
- Boris says Aurora's Canadian and Australian businesses are shrinking, with repeated earnings disappointments and a $6 billion writedown.
- The proposed deal is structured as 80% stock and 20% cash.
- Tim Seymour highlights cleaned-up Canadian balance sheets, excess capacity, Europe's roughly 27% growth, Curaleaf free cash flow, and a potential Nasdaq listing as bullish industry subplots.
Идеи
Curaleaf gets supply and European re-rating upside.
Curaleaf is strategically strong because it has the largest cannabis distribution in Europe/Asia but is supply-constrained; Aurora's Canadian facilities could be nearly doubled in productivity to supply those networks. Curaleaf also has massive tailwinds from double-digit Europe/international growth and potential European regulatory changes that could trigger a significant re-evaluation.
Cannabis industry has multiple bullish catalysts.
The Curaleaf-Aurora bid highlights multiple bullish subplots for the cannabis industry: Canadian companies like Aurora have cleaned up balance sheets, excess capacity now has international destinations, Europe is growing about 27% year over year, Curaleaf has free cash flow for cash-plus-stock M&A, and consolidation could put a Nasdaq listing at stake.
Aurora standalone fundamentals are deteriorating.
Aurora Cannabis is struggling as a standalone company: Canadian and Australian businesses are shrinking quarter after quarter, it has repeatedly disappointed earnings, and it has written off $6 billion of shareholder value, so the asset is better transferred to Curaleaf.
Далее
This CNBC video, published August 18, 2026, features Boris Jordan, Tim Seymour discussing CURLF, MSOS, ACB. 3 trade ideas extracted by AI with direction and confidence scoring.
Speakers: Boris Jordan, Tim Seymour · Tickers: CURLF, MSOS, ACB